Primecap Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27M Sell
28,725
-600
-2% -$51K ﹤0.01% 309
2026
Q1
$2.53M Sell
29,325
-200
-0.7% -$18K ﹤0.01% 297
2025
Q4
$2.58M Sell
29,525
-4,600
-13% -$349K ﹤0.01% 294
2025
Q3
$1.95M Sell
34,125
-1,500
-4% -$86.4K ﹤0.01% 300
2025
Q2
$2.1M Sell
35,625
-2,900
-8% -$187K ﹤0.01% 307
2025
Q1
$2.82M Sell
38,525
-2,700
-7% -$223K ﹤0.01% 295
2024
Q4
$3.41M Sell
41,225
-5,000
-11% -$394K ﹤0.01% 286
2024
Q3
$3.31M Sell
46,225
-1,300
-3% -$91.8K ﹤0.01% 296
2024
Q2
$3.25M Sell
47,525
-1,800
-4% -$108K ﹤0.01% 293
2024
Q1
$2.65M Sell
49,325
-2,800
-5% -$151K ﹤0.01% 304
2023
Q4
$2.78M Sell
52,125
-300
-0.6% -$14.6K ﹤0.01% 301
2023
Q3
$2.6M Buy
+52,425
New +$2.93M ﹤0.01% 300

Other funds holding GMED

Primecap Management's GMED Position: Q2 2026 in Review

Primecap Management reduced its Globus Medical (GMED) stake by 2% in Q2 2026, selling an estimated $51K and leaving 28,725 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #309.

Primecap Management first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.41M in Q4 2024. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Primecap Management held 28,725 shares of Globus Medical worth $2.27M as of Q2 2026.
  • Primecap Management sold 600 Globus Medical shares in Q2 2026, an estimated $51K.
  • Globus Medical made up ﹤0.01% of Primecap Management's portfolio in Q2 2026, its #309 holding.
  • Primecap Management first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
  • Primecap Management's Globus Medical position peaked at $3.41M in Q4 2024.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Primecap Management's 13F filing for Q2 2026, filed 14 Aug 2026.